pindolol has been researched along with sonepiprazole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hatanaka, K; Hidaka, K; Matsumoto, M; Noda-Saita, K; Ohmori, J; Okada, M; Yamaguchi, T | 1 |
Marona-Lewicka, D; Nichols, DE | 1 |
2 other study(ies) available for pindolol and sonepiprazole
Article | Year |
---|---|
Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
Topics: Animals; Anisoles; Benzamides; Binding Sites; Cerebral Cortex; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Ketanserin; Ligands; Macaca fascicularis; Pindolol; Piperazines; Propylamines; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Serotonin; Sulfonamides; Tritium | 1999 |
WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Benzimidazoles; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Drug Therapy, Combination; Pindolol; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D4; Reinforcement Schedule; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Sulfonamides; Tryptamines | 2009 |